Literature DB >> 5417858

Pharmacological significance of biogenic amines in the lungs: 5-hydroxytryptamine.

C Sadavongvivad.   

Abstract

1. A technique for the spectrofluorometric analysis of 5-hydroxytryptamine, histamine, noradrenaline and dopamine in a single lung sample has been developed. The method is a combination of the extraction procedure of Shore & Olin (1958), plus the modification introduced by Hogans (1967) for the analysis of three of the four amines. The fourth amine, histamine, was analysed by the method of Shore, Burkhalter & Cohn (1959), which was combined with the analysis of the other three amines. The combined procedure consisted principally of disintegrating the lung tissue in butanol and subsequent separation of amines for measurement of fluorescence, either directly, as for 5-hydroxytryptamine, or after formation of fluorophores, as for histamine, noradrenaline and dopamine. It has been possible to analyse all four amines from a sample of the lung in which the bronchopulmonary responses have been investigated.2. The concentration of 5-hydroxytryptamine in the lung of seven species ranges from about 0.5 mug/g in the guinea-pig, dog and man to about 7 mug/g in the rabbit. The pulmonary resistance is increased after an injection of 5-hydroxytryptamine in the rat and guinea-pig.3. The guinea-pig is more sensitive to 5-hydroxytryptamine than the rat. In both animal species, the content of 5-hydroxytryptamine in the lung is elevated by administration of either 5-hydroxytryptamine or 5-hydroxytryptophan. In the rat, the administration of p-chlorophenylalanine reduces the content of 5-hydroxytryptamine in the brain but not in the lung.4. It is suggested that the 5-hydroxytryptamine contained in the lung tissue is stored mainly in the platelets and in the mast cells.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5417858      PMCID: PMC1702795          DOI: 10.1111/j.1476-5381.1970.tb08523.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  The occurrence, distribution and physiological role of catecholamines in the nervous system.

Authors:  A CARLSSON
Journal:  Pharmacol Rev       Date:  1959-06       Impact factor: 25.468

2.  5-Hydroxytryptamine and tissue mast cells.

Authors:  J R PARRATT; G B WEST
Journal:  J Physiol       Date:  1957-07-11       Impact factor: 5.182

3.  Serotonin and histamine release during anaphylaxis in the rabbit.

Authors:  T P WAALKES; H WEISSBACH; J BOZICEVICH; S UDENFRIEND
Journal:  J Clin Invest       Date:  1957-07       Impact factor: 14.808

4.  Dopamine in mammalian lung and spleen.

Authors:  U S VON EULER; F LISHAJKO
Journal:  Acta Physiol Pharmacol Neerl       Date:  1957

5.  The antagonism between local anaesthetic drugs and 5-hydroxytryptamine.

Authors:  Y K SINHA; G B WEST
Journal:  J Pharm Pharmacol       Date:  1953-06       Impact factor: 3.765

6.  The nature of the vaso-dilator constituents of certain tissue extracts.

Authors:  C H Best; H H Dale; H W Dudley; W V Thorpe
Journal:  J Physiol       Date:  1927-03-15       Impact factor: 5.182

7.  Changes in pulmonary mechanics induced by melatonin.

Authors:  R Rahamimoff; I Bruderman
Journal:  Life Sci       Date:  1965-07       Impact factor: 5.037

8.  The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine.

Authors:  C C Porter; J A Totaro; A Burcin
Journal:  J Pharmacol Exp Ther       Date:  1965-10       Impact factor: 4.030

9.  Pharmacological significance of biogenic amines in the lungs: noradrenaline and dopamine.

Authors:  D M Aviado; C Sadavongvivad
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739

10.  Serotonin in the developing mammal.

Authors:  G PEPEU; N J GIARMAN
Journal:  J Gen Physiol       Date:  1962-01       Impact factor: 4.086

View more
  17 in total

1.  Influence of dietary deficiency of nicotinamide on lead toxicity in young rats.

Authors:  S J Flora; S K Tandon
Journal:  Biol Trace Elem Res       Date:  1987-10       Impact factor: 3.738

2.  Chelation in metal intoxication XXI: Chelation in lead intoxication during vitamin B complex deficiency.

Authors:  S K Tandon; S J Flora; S Singh
Journal:  Bull Environ Contam Toxicol       Date:  1986-09       Impact factor: 2.151

3.  Quantitative characteristics of the Feyrter cells and neuroepithelial bodies of the fetal rabbit lung in normoxia and short term chronic hypoxia.

Authors:  A Hernandez-Vasquez; J A Will; W B Quay
Journal:  Cell Tissue Res       Date:  1978-05-18       Impact factor: 5.249

4.  Pharmacological significance of biogenic amines in the lungs: histamine.

Authors:  D M Aviado; C Sadavongvivad
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739

5.  Managanese-induced biochemical changes in growing versus adult rats.

Authors:  G S Shukla; M P Dubey; S V Chandra
Journal:  Arch Environ Contam Toxicol       Date:  1980       Impact factor: 2.804

6.  Behavioral and neurochemical changes in rats simultaneously exposed to manganese and lead.

Authors:  A V Chandra; M M Ali; D K Saxena; R C Murthy
Journal:  Arch Toxicol       Date:  1981-11       Impact factor: 5.153

7.  Serotonergic-cholinergic neurotransmitters' function in brain during cadmium exposure in protein restricted rat.

Authors:  K P Das; P C Das; S Dasgupta; C D Dey
Journal:  Biol Trace Elem Res       Date:  1993-02       Impact factor: 3.738

8.  Mediators of passive lung anaphylaxis in the rat.

Authors:  J B Farmer; I M Richards; P Sheard; A M Woods
Journal:  Br J Pharmacol       Date:  1975-09       Impact factor: 8.739

9.  Striatal dopamine turnover and L-dopa treatment after short-term exposure of rats to manganese.

Authors:  G S Shukla; S V Chandra
Journal:  Arch Toxicol       Date:  1981-06       Impact factor: 5.153

10.  Neurochemical changes in rats coexposed to lead and copper.

Authors:  K M Malhotra; G S Shukla; S V Chandra
Journal:  Arch Toxicol       Date:  1982-03       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.